What is MaxCyte's impairment charges?

MaxCyte (MXCT) reported impairment charges of $888.5K in Q4 2025.

What does impairment charges mean?

Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.

MaxCyte MXCT Impairment Charges

Impairment Charges at other companies

Travel + LeisureTNL

$19M—

Atmus Filtration TechnologiesATMU

$2.1M—

Sharplink, Inc. SBET

$191.67M—

The Marygold CompaniesMGLD

$1.4M—

JBG SMITH PropertiesJBGS

$1.5M-82.3%

SynapticsSYNA

$3.45M-78.4%

Segments

By segment

See full

Cell Engineering Technology$3.55M—

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: MaxCyte’s 10-K, filed March 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's impairment charges?: MaxCyte (MXCT) reported impairment charges of $888.5K in Q4 2025.
What does impairment charges mean?: Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.